Jul 25, 2017 7:00 am EDT NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017
May 15, 2017 8:52 am EDT NeoGenomics Reports that its NeoLAB® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer
Apr 26, 2017 7:00 am EDT NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017
Apr 20, 2017 7:00 am EDT NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development
Mar 13, 2017 7:00 am EDT NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing
Feb 22, 2017 7:00 am EST NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
Feb 8, 2017 11:22 am EST NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017
